Inhibition of invasion and experimental metastasis of murine melanoma cells by Ipomoea obscura (L.) is mediated through the down-regulation of inflammatory mediators and matrix-metalloproteinases

Journal of Experimental Therapeutics and Oncology

Volumn 9, Issue 2, 2011, Pages 139-151

  Hamsa, Thayele Purayil ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

B16F 10 melanoma cells; Extracellular matrix; Invasion; Migration; Transcription factor; Tumor nodule

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANTIMETASTATIC AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; IPOMOEA OBSCURA EXTRACT; PLANT EXTRACT; SIALIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; IPOMOEA; IPOMOEA OBSCURA; LUNG METASTASIS; MALE; MELANOMA CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; INFLAMMATION MEDIATORS; IPOMOEA; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 79959220229     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Choi MA, Kim SH, Chung WY, Hwang JK, Park KK. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem Biophys Res Commun 326: 210-7, 2005. (Pubitemid 39573221)
2. Weng CJ, Chau CF, Hsieh YS, Yang SF, Yen GC. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29: 147-56, 2008.
3. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-85, 2005.
4. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3: 489-501, 2003. (Pubitemid 37328837)
5. Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler- Stevenson WG. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-91, 1990. (Pubitemid 20323672)
6. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104 ( Pt 4): 991-9, 1993. (Pubitemid 23154306)
7. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler- Stevenson WG. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83: 775-9, 1991.
8. Johnson SM, Wang X, Mark Evers B. Triptolide Inhibits Proliferation and Migration of Colon Cancer Cells by Inhibition of Cell Cycle Regulators and Cytokine Receptors. J Surg Res, 2009.
9. Kim JK, Shin EK, Park JH, Kim YH. Antitumor and antimetastatic effects of licochalcone A in mouse models. J Mol Med 88: 829-38, 2010.
10. Csiszar A, Szentes T, Haraszti B, Balazs A, Petranyi GG, Pocsik E. The pattern of cytokine gene expression in human colorectal carcinoma. Pathol Oncol Res 10: 109-16, 2004. (Pubitemid 38915604)
11. Hoki Y, Hiraku Y, Ma N, Murata M, Matsumine A, Nagahama M, Shintani K, Uchida A, Kawanishi S. iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis. Cancer Sci 98: 163-8, 2007. (Pubitemid 44941867)
12. Igawa S, Hayashi I, Tanaka N, Hiruma H, Majima M, Kawakami T, Hirose M, Masuda N, Kobayashi H. Nitric oxide generated by iNOS reduces deformability of Lewis lung carcinoma cells. Cancer Sci 95: 342-7, 2004. (Pubitemid 38519475)
13. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2: 149-56, 2001. (Pubitemid 33585926)
14. Hussain T, Gupta S, Mukhtar H. Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 191: 125-35, 2003. (Pubitemid 36255597)
15. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24: 96-102, 2003. (Pubitemid 36135884)
16. Lee SJ, Chung IM, Kim MY, Park KD, Park WH, Moon HI. Inhibition of lung metastasis in mice by oligonol. Phytother Res 23: 1043-6, 2009.
17. Savithramma N, Sulochana C, Rao KN. Ethnobotanical survey of plants used to treat asthma in Andhra Pradesh, India. J Ethnopharmacol 113: 54-61, 2007. (Pubitemid 47079163)
18. Jenett-Siems K, Weigl R, Kaloga M, Schulz J, Eich E. Ipobscurines C and D: macrolactam-type indole alkaloids from the seeds of Ipomoea obscura. Phytochemistry 62: 1257-63, 2003. (Pubitemid 36383598)
19. Hamsa TP, Kuttan G. Evaluation of the Anti-inflammatory and Anti-tumor Effect of Ipomoea obscura (L) and Its Mode of Action Through the Inhibition of Pro Inflammatory Cytokines, Nitric Oxide and COX-2. Inflammation, 2010, (In press).
20. Hamsa TP, Kuttan G. Ipomoea obscura (L.) enhances the functions of immunological effector cells, inhibits proinflammatory cytokines and nitric oxide production by LPS induced macrophages. Immunopharmacol Immunotoxicol 31: 222-9, 2009.
21. Cole SP. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17: 259-63, 1986. (Pubitemid 16070936)
22. Campling BG, Pym J, Baker HM, Cole SP, Lam YM. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 63: 75-83, 1991.
23. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-45, 1987. (Pubitemid 17082655)
24. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-89, 1983.
25. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46: 1-7, 1986. (Pubitemid 16189019)
26. Bergman I, Loxley R. The determination of hydroxyproline in urine hydrolysates. Clin Chim Acta 27: 347-9, 1970.
27. Elson LA, Morgan WT. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 27: 1824-8, 1933.
28. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 4: 330-4, 1962.
29. Skoza L, Mohos S. Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation. Biochem J 159: 457-62, 1976.
30. Szasz G. Reaction-rate method for gamma-glutamyltransferase activity in serum. Clin Chem 22: 2051-5, 1976.
31. Hill LL, Perussia B, McCue PA, Korngold R. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res 54: 763-70, 1994. (Pubitemid 24068334)
32. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem 112: 3-25, 2010.
33. Arvelo F,Cotte C. [Metalloproteinases in tumor progression. Review]. Invest Clin 47: 185-205, 2006.
34. Imanaka H, Koide H, Shimizu K, Asai T, Kinouchi Shimizu N, Ishikado A, Makino T, Oku N. Chemoprevention of tumor metastasis by liposomal beta-sitosterol intake. Biol Pharm Bull 31: 400-4, 2008. (Pubitemid 351442135)
35. Wang S, Liu Q, Zhang Y, Liu K, Yu P, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer 8: 81, 2009.
36. Kim SA, Lee HJ, Ahn KS, Lee EO, Choi SH, Jung SJ, Kim JY, Baek N, Kim SH. Paeonol exerts anti-angiogenic and antimetastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases. Biol Pharm Bull 32: 1142-7, 2009.
37. Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol 2: 466-71, 1998. (Pubitemid 128645699)
38. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23, 2001. (Pubitemid 32591662)
39. Duffy MJ, Duggan C, Maguire T, Mulcahy K, Elvin P, McDermott E, Fennelly JJ, O'Higgins N. Urokinase plasminogen activator as a predictor of aggressive disease in breast cancer. Enzyme Protein 49: 85-93, 1996. (Pubitemid 26181739)
40. Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245-52, 2002. (Pubitemid 34311378)
41. Chen CH, Sheu MT, Chen TF, Wang YC, Hou WC, Liu DZ, Chung TC, Liang YC. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochem Pharmacol 72: 1001-9, 2006.
42. Dong G, Chen Z, Kato T, Van Waes C. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res 59: 3495-504, 1999. (Pubitemid 29334514)
43. Kwon HK, Jeon WK, Hwang JS, Lee CG, So JS, Park JA, Ko BS, Im SH. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8 + T cells. Cancer Lett 278: 174-82, 2009.
44. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 6: 521-34, 2006. (Pubitemid 43980541)
45. Chen YC, Sosnoski DM, Gandhi UH, Novinger LJ, Prabhu KS, Mastro AM. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. Carcinogenesis 30: 1941-8, 2009.
46. Park JH, Jeong YJ, Park KK, Cho HJ, Chung IK, Min KS, Kim M, Lee KG, Yeo JH, Chang YC. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells 29: 209-15, 2010.
47. Hamsa TP, Kuttan G. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A. Immunopharmacol Immunotoxicol, 2010 (In press).
48. Liotta LA. Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture. Am J Pathol 117: 339-48, 1984. (Pubitemid 15182474)
49. Venkatesan N, Punithavathi D, Chandrakasan G. Biochemical and connective tissue changes in cyclophosphamide-induced lung fibrosis in rats. Biochem Pharmacol 56: 895-904, 1998. (Pubitemid 28458983)
50. Khadapkar SV, Sheth NA, Bhide SV. Independence of sialic acid levels in normal and malignant growth. Cancer Res 35: 1520-3, 1975.
51. Kloppel TM, Keenan TW, Freeman MJ, Morre DJ. Glycolipid-bound sialic acid in serum: increased levels in mice and humans bearing mammary carcinomas. Proc Natl Acad Sci U S A 74: 3011-3, 1977.
52. Idiz N, Guvendik G, Bosgelmez, II, Soylemezoglu T, Dogan YB, Ilhan I. Serum sialic acid and gamma-glutamyltransferase levels in alcohol-dependent individuals. Forensic Sci Int 146 Suppl: S67-70, 2004.
53. Obrador E, Carretero J, Ortega A, Medina I, Rodilla V, Pellicer JA, Estrela JM. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 35: 74-81, 2002. (Pubitemid 34032545)